Abe, N., Kato, M., Kono, M., Fujieda, Y., Ohira, H., Tsujino, I., Oyama-Manabe, N., Oku, K., Bohgaki, T., Yasuda, S., et al. (2020). Right ventricular dimension index by cardiac magnetic resonance for prognostication in connective tissue diseases and pulmonary hypertension. Rheumatology (Oxford) 59, 622-633.
Alabed, S., Shahin, Y., Garg, P., Alandejani, F., Johns, C.S., Lewis, R.A., Condliffe, R., Wild, J.M., Kiely, D.G., and Swift, A.J. (2020). Cardiac-MRI Predicts Clinical Worsening and Mortality in Pulmonary Arterial Hypertension: A Systematic Review and Meta-Analysis. JACC Cardiovasc Imaging. 2021 May;14(5):931-942.
An, Q., Yan, W., Zhao, Y., and Yu, K. (2018). Enhanced neutrophil autophagy and increased concentrations of IL-6, IL-8, IL-10 and MCP-1 in rheumatoid arthritis. Int Immunopharmacol 65, 119-128.
Bae, S., Saggar, R., Bolster, M.B., Chung, L., Csuka, M.E., Derk, C., Domsic, R., Fischer, A., Frech, T., Goldberg, A., et al. (2012). Baseline characteristics and follow-up in patients with normal haemodynamics versus borderline mean pulmonary arterial pressure in systemic sclerosis: results from the PHAROS registry. Ann Rheum Dis 71, 1335-1342.
Bergrath, E., Gerber, R.A., Gruben, D., Lukic, T., Makin, C., and Wallenstein, G. (2017). Tofacitinib versus Biologic Treatments in Moderate-to-Severe Rheumatoid Arthritis Patients Who Have Had an Inadequate Response to Nonbiologic DMARDs: Systematic Literature Review and Network Meta-Analysis. Int J Rheumatol 2017, 8417249. Epub 2017 Mar 9.
Bottini, N., and Firestein, G.S. (2013). Duality of fibroblast-like synoviocytes in RA: passive responders and imprinted aggressors. Nat Rev Rheumatol 9, 24-33.
Bourji, K.I., Kelemen, B.W., Mathai, S.C., Damico, R.L., Kolb, T.M., Mercurio, V., Cozzi, F., Tedford, R.J., and Hassoun, P.M. (2017). Poor survival in patients with scleroderma and pulmonary hypertension due to heart failure with preserved ejection fraction. Pulm Circ 7, 409-420.
Butt, S.A., Jeppesen, J.L., Torp-Pedersen, C., Sam, F., Gislason, G.H., Jacobsen, S., and Andersson, C. (2019). Cardiovascular Manifestations of Systemic Sclerosis: A Danish Nationwide Cohort Study. J Am Heart Assoc. 2019 Sep 3;8(17):e013405.
Chang, L., Feng, X., and Gao, W. (2019). Proliferation of rheumatoid arthritis fibroblast- like synoviocytes is enhanced by IL-17-mediated autophagy through STAT3 activation. Connect Tissue Res 60, 358-366.
Chen, M., Li, M., Zhang, N., Sun, W., Wang, H., and Wei, W. (2021). Mechanism of miR-218-5p in autophagy, apoptosis and oxidative stress in rheumatoid arthritis synovial fibroblasts is mediated by KLF9 and JAK/STAT3 pathways. J Investig Med. 2021 Feb 8;69(4):824-832.
Chen, R., Sun, Y., Cui, X., Ji, Z., Kong, X., Wu, S., Huang, Q., Dai, X., Zhang, S., Ma, L., et al. (2019). Autophagy promotes aortic adventitial fibrosis via the IL-6/Jak1 signaling pathway in Takayasu's arteritis. J Autoimmun 99, 39-47.
Chung, L., Liu, J., Parsons, L., Hassoun, P.M., McGoon, M., Badesch, D.B., Miller, D.P., Nicolls, M.R., and Zamanian, R.T. (2010). Characterization of connective tissue disease- associated pulmonary arterial hypertension from REVEAL: identifying systemic sclerosis as a unique phenotype. Chest 138, 1383-1394.
Coghlan, J.G., Denton, C.P., Grunig, E., Bonderman, D., Distler, O., Khanna, D., Muller- Ladner, U., Pope, J.E., Vonk, M.C., Doelberg, M., et al. (2014). Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study. Ann Rheum Dis 73, 1340-1349.
Dengjel, J., Schoor, O., Fischer, R., Reich, M., Kraus, M., Muller, M., Kreymborg, K., Altenberend, F., Brandenburg, J., Kalbacher, H., et al. (2005). Autophagy promotes MHC class II presentation of peptides from intracellular source proteins. Proc Natl Acad Sci U S A 102, 7922-7927.
Di Cesare, E., Battisti, S., Di Sibio, A., Cipriani, P., Giacomelli, R., Liakouli, V., Ruscitti, P., and Masciocchi, C. (2013). Early assessment of sub-clinical cardiac involvement in systemic sclerosis (SSc) using delayed enhancement cardiac magnetic resonance (CE- MRI). Eur J Radiol 82, e268-273.
Diller, M., Hasseli, R., Hulser, M.L., Aykara, I., Frommer, K., Rehart, S., Muller-Ladner, U., and Neumann, E. (2019). Targeting Activated Synovial Fibroblasts in Rheumatoid Arthritis by Peficitinib. Front Immunol 10, 541.
Dong, G., You, M., Fan, H., Ding, L., Sun, L., and Hou, Y. (2015). STS-1 promotes IFN- alpha induced autophagy by activating the JAK1-STAT1 signaling pathway in B cells. Eur J Immunol 45, 2377-2388.
Emori, T., Kasahara, M., Sugahara, S., Hashimoto, M., Ito, H., Narumiya, S., Higashi, Y., and Fujii, Y. (2020). Role of JAK-STAT signaling in the pathogenic behavior of fibroblast-like synoviocytes in rheumatoid arthritis: Effect of the novel JAK inhibitor peficitinib. Eur J Pharmacol. 2020 Sep 5;882:173238.
Faludi, R., Kolto, G., Bartos, B., Csima, G., Czirjak, L., and Komocsi, A. (2014). Five- year follow-up of left ventricular diastolic function in systemic sclerosis patients: determinants of mortality and disease progression. Semin Arthritis Rheum 44, 220-227.
Fayyaz, A.U., Edwards, W.D., Maleszewski, J.J., Konik, E.A., DuBrock, H.M., Borlaug, B.A., Frantz, R.P., Jenkins, S.M., and Redfield, M.M. (2018). Global Pulmonary Vascular Remodeling in Pulmonary Hypertension Associated With Heart Failure and Preserved or Reduced Ejection Fraction. Circulation 137, 1796-1810.
Fernandes, F., Ramires, F.J., Arteaga, E., Ianni, B.M., Bonfa, E.S., and Mady, C. (2003). Cardiac remodeling in patients with systemic sclerosis with no signs or symptoms of heart failure: an endomyocardial biopsy study. J Card Fail 9, 311-317.
Fuhrmann, J., Clancy, K.W., and Thompson, P.R. (2015). Chemical biology of protein arginine modifications in epigenetic regulation. Chem Rev 115, 5413-5461.
Galie, N., Hoeper, M.M., Humbert, M., Torbicki, A., Vachiery, J.L., Barbera, J.A., Beghetti, M., Corris, P., Gaine, S., Gibbs, J.S., et al. (2009). Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J 30, 2493-2537.
Genovese, M.C., Smolen, J.S., Weinblatt, M.E., Burmester, G.R., Meerwein, S., Camp, H.S., Wang, L., Othman, A.A., Khan, N., Pangan, A.L., et al. (2016). Efficacy and Safety of ABT-494, a Selective JAK-1 Inhibitor, in a Phase IIb Study in Patients With Rheumatoid Arthritis and an Inadequate Response to Methotrexate. Arthritis Rheumatol 68, 2857-2866.
Guillen-Del Castillo, A., Callejas-Moraga, E.L., Garcia, G., Rodriguez-Palomares, J.F., Roman, A., Berastegui, C., Lopez-Meseguer, M., Domingo, E., Fonollosa-Pla, V., and Simeon-Aznar, C.P. (2017). High sensitivity and negative predictive value of the DETECT algorithm for an early diagnosis of pulmonary arterial hypertension in systemic sclerosis: application in a single center. Arthritis Res Ther. 2017 Jun 14;19(1):135.
Haan, C., Rolvering, C., Raulf, F., Kapp, M., Druckes, P., Thoma, G., Behrmann, I., and Zerwes, H.G. (2011). Jak1 has a dominant role over Jak3 in signal transduction through gammac-containing cytokine receptors. Chem Biol 18, 314-323.
Hachulla, A.L., Launay, D., Gaxotte, V., de Groote, P., Lamblin, N., Devos, P., Hatron, P.Y., Beregi, J.P., and Hachulla, E. (2009). Cardiac magnetic resonance imaging in systemic sclerosis: a cross-sectional observational study of 52 patients. Ann Rheum Dis 68, 1878-1884.
Hao, Y., Thakkar, V., Stevens, W., Morrisroe, K., Prior, D., Rabusa, C., Youssef, P., Gabbay, E., Roddy, J., Walker, J., et al. (2015). A comparison of the predictive accuracy of three screening models for pulmonary arterial hypertension in systemic sclerosis. Arthritis Res Ther . 2015 Jan 18;17(1):7.
Hofmann, H.D., and Kirsch, M. (2012). JAK2-STAT3 signaling: A novel function and a novel mechanism. JAKSTAT 1, 191-193.
Hosseini, A., Gharibi, T., Marofi, F., Javadian, M., Babaloo, Z., and Baradaran, B. (2020). Janus kinase inhibitors: A therapeutic strategy for cancer and autoimmune diseases. J Cell Physiol 235, 5903-5924.
Hsu, S., Kokkonen-Simon, K.M., Kirk, J.A., Kolb, T.M., Damico, R.L., Mathai, S.C., Mukherjee, M., Shah, A.A., Wigley, F.M., Margulies, K.B., et al. (2018). Right Ventricular Myofilament Functional Differences in Humans With Systemic Sclerosis- Associated Versus Idiopathic Pulmonary Arterial Hypertension. Circulation 137, 2360- 2370.
Humbert, M., Yaici, A., de Groote, P., Montani, D., Sitbon, O., Launay, D., Gressin, V., Guillevin, L., Clerson, P., Simonneau, G., et al. (2011). Screening for pulmonary arterial hypertension in patients with systemic sclerosis: clinical characteristics at diagnosis and long-term survival. Arthritis Rheum 63, 3522-3530.
Ireland, J.M., and Unanue, E.R. (2011). Autophagy in antigen-presenting cells results in presentation of citrullinated peptides to CD4 T cells. J Exp Med 208, 2625-2632.
Jamilloux, Y., El Jammal, T., Vuitton, L., Gerfaud-Valentin, M., Kerever, S., and Seve, P. (2019). JAK inhibitors for the treatment of autoimmune and inflammatory diseases. Autoimmun Rev. 2019 Nov;18(11):102390.
Kahan, A., and Allanore, Y. (2006). Primary myocardial involvement in systemic sclerosis. Rheumatology (Oxford) 45 Suppl 4, iv14-17.
Kameda, H., Takeuchi, T., Yamaoka, K., Oribe, M., Kawano, M., Yokoyama, M., Pangan, A.L., Konishi, Y., Meerwein, S., and Tanaka, Y. (2021). Efficacy and safety of upadacitinib over 84 weeks in Japanese patients with rheumatoid arthritis (SELECT- SUNRISE). Arthritis Res Ther. 2021 Jan 6;23(1):9.
Kang, R., Zeh, H.J., Lotze, M.T., and Tang, D. (2011). The Beclin 1 network regulates autophagy and apoptosis. Cell Death Differ 18, 571-580.
Kato, M., and Atsumi, T. (2018). Pulmonary arterial hypertension associated with connective tissue diseases: A review focusing on distinctive clinical aspects. Eur J Clin Invest. 2018 Feb;48(2).
Kato, M., Ospelt, C., Gay, R.E., Gay, S., and Klein, K. (2014). Dual role of autophagy in stress-induced cell death in rheumatoid arthritis synovial fibroblasts. Arthritis Rheumatol 66, 40-48.
Kato, M., Sugimoto, A., and Atsumi, T. (2020). Diagnostic and prognostic markers and treatment of connective tissue disease-associated pulmonary arterial hypertension: current recommendations and recent advances. Expert Rev Clin Immunol 16, 993-1004. Khanna, D., Gladue, H., Channick, R., Chung, L., Distler, O., Furst, D.E., Hachulla, E., Humbert, M., Langleben, D., Mathai, S.C., et al. (2013). Recommendations for screening and detection of connective tissue disease-associated pulmonary arterial hypertension. Arthritis Rheum 65, 3194-3201.
Kim, E.K., Kwon, J.E., Lee, S.Y., Lee, E.J., Kim, D.S., Moon, S.J., Lee, J., Kwok, S.K., Park, S.H., and Cho, M.L. (2017). IL-17-mediated mitochondrial dysfunction impairs apoptosis in rheumatoid arthritis synovial fibroblasts through activation of autophagy. Cell Death Dis. 2017 Jan 19;8(1):e2565.
Klareskog, L., Catrina, A.I., and Paget, S. (2009). Rheumatoid arthritis. Lancet 373, 659- 672.
Klein, K., and Gay, S. (2015). Epigenetics in rheumatoid arthritis. Curr Opin Rheumatol 27, 76-82.
Krikeerati, T., Pussadhamma, B., Mahakkanukrauh, A., Suwannaroj, S., Nanagara, R., and Foocharoen, C. (2021). Associated factors of early-onset pulmonary hypertension and clinical difference between early- and late-onset pulmonary hypertension in Thai systemic sclerosis. Mod Rheumatol 31, 649-656.
Lammi, M.R., Saketkoo, L.A., Gordon, J.K., and Steen, V.D. (2018). Changes in hemodynamic classification over time are common in systemic sclerosis-associated pulmonary hypertension: insights from the PHAROS cohort. Pulm Circ 2018; 8(2) 1–7.
Lang, R.M., Badano, L.P., Mor-Avi, V., Afilalo, J., Armstrong, A., Ernande, L., Flachskampf, F.A., Foster, E., Goldstein, S.A., Kuznetsova, T., et al. (2015). Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 28, 1-39 e14.
Lee, W.S., Kato, M., Sugawara, E., Kono, M., Kudo, Y., Kono, M., Fujieda, Y., Bohgaki, T., Amengual, O., Oku, K., et al. (2020). Protective Role of Optineurin Against Joint Destruction in Rheumatoid Arthritis Synovial Fibroblasts. Arthritis Rheumatol 72, 1493- 1504.
Lei, Y., Zhang, X., Lin, H., Feng, Y., Wang, J., and Luo, R. (2021). The effects of oral treatment for systemic sclerosis related pulmonary arterial hypertension: A systematic review and meta-analysis. Mod Rheumatol 31, 151-161.
LeRoy, E.C., Black, C., Fleischmajer, R., Jablonska, S., Krieg, T., Medsger, T.A., Jr., Rowell, N., and Wollheim, F. (1988). Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 15, 202-205.
Maxwell, L.J., and Singh, J.A. (2010). Abatacept for rheumatoid arthritis: a Cochrane systematic review. J Rheumatol 37, 234-245.
McInnes, I.B., Byers, N.L., Higgs, R.E., Lee, J., Macias, W.L., Na, S., Ortmann, R.A., Rocha, G., Rooney, T.P., Wehrman, T., et al. (2019). Comparison of baricitinib, upadacitinib, and tofacitinib mediated regulation of cytokine signaling in human leukocyte subpopulations. Arthritis Res Ther 21, 183.
McInnes, I.B., and Schett, G. (2011). The pathogenesis of rheumatoid arthritis. N Engl J Med 365, 2205-2219.
McKee, P.A., Castelli, W.P., McNamara, P.M., and Kannel, W.B. (1971). The natural history of congestive heart failure: the Framingham study. N Engl J Med 285, 1441-1446. Meune, C., Vignaux, O., Kahan, A., and Allanore, Y. (2010). Heart involvement in systemic sclerosis: evolving concept and diagnostic methodologies. Arch Cardiovasc Dis 103, 46-52.
Mizoguchi, F., Slowikowski, K., Wei, K., Marshall, J.L., Rao, D.A., Chang, S.K., Nguyen, H.N., Noss, E.H., Turner, J.D., Earp, B.E., et al. (2018). Functionally distinct disease- associated fibroblast subsets in rheumatoid arthritis. Nat Commun. 2018 Feb 23;9(1):789.
Morrisroe, K., Stevens, W., Huq, M., Prior, D., Sahhar, J., Ngian, G.S., Celermajer, D., Zochling, J., Proudman, S., Nikpour, M., et al. (2017). Survival and quality of life in incident systemic sclerosis-related pulmonary arterial hypertension. Arthritis Res Ther. 2017 Jun 2;19(1):122.
Nagueh, S.F., Smiseth, O.A., Appleton, C.P., Byrd, B.F., 3rd, Dokainish, H., Edvardsen, T., Flachskampf, F.A., Gillebert, T.C., Klein, A.L., Lancellotti, P., et al. (2016). Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 29, 277-314.
Nathan, S.D., Barbera, J.A., Gaine, S.P., Harari, S., Martinez, F.J., Olschewski, H., Olsson, K.M., Peacock, A.J., Pepke-Zaba, J., Provencher, S., et al. (2019). Pulmonary hypertension in chronic lung disease and hypoxia.. Eur Respir J 2019; 53: 1801914
Nguyen, H.N., Noss, E.H., Mizoguchi, F., Huppertz, C., Wei, K.S., Watts, G.F.M., and Brenner, M.B. (2017). Autocrine Loop Involving IL-6 Family Member LIF, LIF Receptor, and STAT4 Drives Sustained Fibroblast Production of Inflammatory Mediators. Immunity 46, 220-232.
O'Shea, J.J., Schwartz, D.M., Villarino, A.V., Gadina, M., McInnes, I.B., and Laurence, A. (2015). The JAK-STAT pathway: impact on human disease and therapeutic intervention. Annu Rev Med 66, 311-328.
Okada, Y., Wu, D., Trynka, G., Raj, T., Terao, C., Ikari, K., Kochi, Y., Ohmura, K., Suzuki, A., Yoshida, S., et al. (2014). Genetics of rheumatoid arthritis contributes to biology and drug discovery. Nature 506, 376-381.
Orlandi, M., Lepri, G., Damiani, A., Barsotti, S., Di Battista, M., Codullo, V., Della Rossa, A., Guiducci, S., and Allanore, Y. (2020). One year in review 2020: systemic sclerosis. Clin Exp Rheumatol 38 Suppl 125, 3-17.
Overbeek, M.J., Vonk, M.C., Boonstra, A., Voskuyl, A.E., Vonk-Noordegraaf, A., Smit, E.F., Dijkmans, B.A., Postmus, P.E., Mooi, W.J., Heijdra, Y., et al. (2009). Pulmonary arterial hypertension in limited cutaneous systemic sclerosis: a distinctive vasculopathy. Eur Respir J 34, 371-379.
Sabeh, F., Fox, D., and Weiss, S.J. (2010). Membrane-type I matrix metalloproteinase- dependent regulation of rheumatoid arthritis synoviocyte function. J Immunol 184, 6396- 6406.
Sandmeier, B., Jager, V.K., Nagy, G., Carreira, P.E., Tzankov, A., Widuchowska, M., Antic, M., Distler, O., Reichert, H., Distler, J.H., et al. (2015). Autopsy versus clinical findings in patients with systemic sclerosis in a case series from patients of the EUSTAR database. Clin Exp Rheumatol 33, S75-79.
Sasaki, N., Kamataki, A., and Sawai, T. (2011). A histopathological study of pulmonary hypertension in connective tissue disease. Allergol Int 60, 411-417.
Scher, J.U., Littman, D.R., and Abramson, S.B. (2016). Microbiome in Inflammatory Arthritis and Human Rheumatic Diseases. Arthritis Rheumatol 68, 35-45.
Silman, A.J., and Pearson, J.E. (2002). Epidemiology and genetics of rheumatoid arthritis. Arthritis Res 4 Suppl 3, S265-272.
Simonneau, G., Montani, D., Celermajer, D.S., Denton, C.P., Gatzoulis, M.A., Krowka, M., Williams, P.G., and Souza, R. (2019). Haemodynamic definitions and updated clinical classification of pulmonary hypertension. Eur Respir J 2019; 53: 1801913
Smolen, J.S., and Steiner, G. (2003). Therapeutic strategies for rheumatoid arthritis. Nat Rev Drug Discov 2, 473-488.
Smolen, J.S., Tohidast-Akrad, M., Gal, A., Kunaver, M., Eberl, G., Zenz, P., Falus, A., and Steiner, G. (1996). The role of T-lymphocytes and cytokines in rheumatoid arthritis. Scand J Rheumatol 25, 1-4.
Sobanski, V., Giovannelli, J., Lynch, B.M., Schreiber, B.E., Nihtyanova, S.I., Harvey, J., Handler, C.E., Denton, C.P., and Coghlan, J.G. (2016). Characteristics and Survival of Anti-U1 RNP Antibody-Positive Patients With Connective Tissue Disease-Associated Pulmonary Arterial Hypertension. Arthritis Rheumatol 68, 484-493.
Strand, V., Schiff, M., Tundia, N., Friedman, A., Meerwein, S., Pangan, A., Ganguli, A., Fuldeore, M., Song, Y., and Pope, J. (2019). Effects of upadacitinib on patient-reported outcomes: results from SELECT-BEYOND, a phase 3 randomized trial in patients with rheumatoid arthritis and inadequate responses to biologic disease-modifying antirheumatic drugs. Arthritis Res Ther. 2019 Dec 2;21(1):263.
Sugawara, E., Kato, M., Kudo, Y., Lee, W., Hisada, R., Fujieda, Y., Oku, K., Bohgaki, T., Amengual, O., Yasuda, S., et al. (2020). Autophagy promotes citrullination of VIM (vimentin) and its interaction with major histocompatibility complex class II in synovial fibroblasts. Autophagy 16, 946-955.
Suzuki, A., Yamada, R., Chang, X., Tokuhiro, S., Sawada, T., Suzuki, M., Nagasaki, M., Nakayama-Hamada, M., Kawaida, R., Ono, M., et al. (2003). Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis. Nat Genet 34, 395-402.
Syversen, S.W., Goll, G.L., van der Heijde, D., Landewe, R., Lie, B.A., Odegard, S., Uhlig, T., Gaarder, P.I., and Kvien, T.K. (2010). Prediction of radiographic progression in rheumatoid arthritis and the role of antibodies against mutated citrullinated vimentin: results from a 10-year prospective study. Ann Rheum Dis 69, 345-351.
Takeuchi, T., Tanaka, Y., Tanaka, S., Kawakami, A., Iwasaki, M., Katayama, K., Rokuda, M., Izutsu, H., Ushijima, S., Kaneko, Y., et al. (2019). Efficacy and safety of peficitinib (ASP015K) in patients with rheumatoid arthritis and an inadequate response to methotrexate: results of a phase III randomised, double-blind, placebo-controlled trial (RAJ4) in Japan. Ann Rheum Dis 78, 1305-1319.
Tanaka, Y., Kuwana, M., Fujii, T., Kameda, H., Muro, Y., Fujio, K., Itoh, Y., Yasuoka, H., Fukaya, S., Ashihara, K., et al. (2020). 2019 Diagnostic criteria for mixed connective tissue disease (MCTD): From the Japan research committee of the ministry of health, labor, and welfare for systemic autoimmune diseases. Mod Rheumatol, 1-5.
Tanaka, Y., Okumura, H., Kim, S., Dorey, J., Wojciechowski, P., Chorazy, J., Kato, D., and Schultz, N.M. (2021). Comparative Efficacy and Safety of Peficitinib Versus Tofacitinib and Baricitinib for Treatment of Rheumatoid Arthritis: A Systematic Review and Network Meta-Analysis. Rheumatol Ther 8, 729-750.
Tennoe, A.H., Murbraech, K., Andreassen, J.C., Fretheim, H., Garen, T., Gude, E., Andreassen, A., Aakhus, S., Molberg, O., and Hoffmann-Vold, A.M. (2018). Left Ventricular Diastolic Dysfunction Predicts Mortality in Patients With Systemic Sclerosis. J Am Coll Cardiol 72, 1804-1813.
Thakkar, V., Stevens, W.M., Prior, D., Moore, O.A., Byron, J., Liew, D., Patterson, K., Hissaria, P., Roddy, J., Zochling, J., et al. (2012). N-terminal pro-brain natriuretic peptide in a novel screening algorithm for pulmonary arterial hypertension in systemic sclerosis: a case-control study. Arthritis Res Ther. 2012 Jun 12;14(3):R143.
Tyndall, A.J., Bannert, B., Vonk, M., Airo, P., Cozzi, F., Carreira, P.E., Bancel, D.F., Allanore, Y., Muller-Ladner, U., Distler, O., et al. (2010). Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database. Ann Rheum Dis 69, 1809-1815.
Tzelepis, G.E., Kelekis, N.L., Plastiras, S.C., Mitseas, P., Economopoulos, N., Kampolis, C., Gialafos, E.J., Moyssakis, I., and Moutsopoulos, H.M. (2007). Pattern and distribution of myocardial fibrosis in systemic sclerosis: a delayed enhanced magnetic resonance imaging study. Arthritis Rheum 56, 3827-3836.
Ummarino, D. (2016). Rheumatoid arthritis: RA-BEACON illuminates baricitinib. Nat Rev Rheumatol. 2016 Jun;12(6):313.
Utsunomiya, A., Hasegawa, M., Oyama, N., Asano, Y., Endo, H., Fujimoto, M., Goto, D., Ishikawa, O., Kawaguchi, Y., Kuwana, M., et al. (2020). Clinical course of Japanese patients with early systemic sclerosis: A multicenter, prospective, observational study. Mod Rheumatol, 1-9.
Vachiery, J.L., Tedford, R.J., Rosenkranz, S., Palazzini, M., Lang, I., Guazzi, M., Coghlan, G., Chazova, I., and De Marco, T. (2019). Pulmonary hypertension due to left heart disease. Eur Respir J. 2019 Jan 24;53(1):1801897.
Valecka, J., Almeida, C.R., Su, B., Pierre, P., and Gatti, E. (2018). Autophagy and MHC- restricted antigen presentation. Mol Immunol 99, 163-170.
Valerio, C.J., Schreiber, B.E., Handler, C.E., Denton, C.P., and Coghlan, J.G. (2013). Borderline mean pulmonary artery pressure in patients with systemic sclerosis: transpulmonary gradient predicts risk of developing pulmonary hypertension. Arthritis Rheum 65, 1074-1084.
van den Hoogen, F., Khanna, D., Fransen, J., Johnson, S.R., Baron, M., Tyndall, A., Matucci-Cerinic, M., Naden, R.P., Medsger, T.A., Jr., Carreira, P.E., et al. (2013). 2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative. Arthritis Rheum 65, 2737-2747.
Vandecasteele, E., Drieghe, B., Melsens, K., Thevissen, K., De Pauw, M., Deschepper, E., Decuman, S., Bonroy, C., Piette, Y., De Keyser, F., et al. (2017). Screening for pulmonary arterial hypertension in an unselected prospective systemic sclerosis cohort. Eur Respir J. 2017 May 11;49(5):1602275.
Vieira, M.C., Zwillich, S.H., Jansen, J.P., Smiechowski, B., Spurden, D., and Wallenstein, G.V. (2016). Tofacitinib Versus Biologic Treatments in Patients With Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Tumor Necrosis Factor Inhibitors: Results From a Network Meta-analysis. Clin Ther 38, 2628-2641 e2625.
Volkov, M., van Schie, K.A., and van der Woude, D. (2020). Autoantibodies and B Cells: The ABC of rheumatoid arthritis pathophysiology. Immunol Rev 294, 148-163.
Vossenaar, E.R., Radstake, T.R., van der Heijden, A., van Mansum, M.A., Dieteren, C., de Rooij, D.J., Barrera, P., Zendman, A.J., and van Venrooij, W.J. (2004). Expression and activity of citrullinating peptidylarginine deiminase enzymes in monocytes and macrophages. Ann Rheum Dis 63, 373-381.
Weatherald, J., Boucly, A., Launay, D., Cottin, V., Prevot, G., Bourlier, D., Dauphin, C., Chaouat, A., Savale, L., Jais, X., et al. (2018). Haemodynamics and serial risk assessment in systemic sclerosis associated pulmonary arterial hypertension. Eur Respir J. 2018 Oct 18;52(4):1800678.
Writing Committee, M., Yancy, C.W., Jessup, M., Bozkurt, B., Butler, J., Casey, D.E., Jr., Drazner, M.H., Fonarow, G.C., Geraci, S.A., Horwich, T., et al. (2013). 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation 128, e240-327.
Zhang, F., Wei, K., Slowikowski, K., Fonseka, C.Y., Rao, D.A., Kelly, S., Goodman, S.M., Tabechian, D., Hughes, L.B., Salomon-Escoto, K., et al. (2019). Defining inflammatory cell states in rheumatoid arthritis joint synovial tissues by integrating single-cell transcriptomics and mass cytometry. Nat Immunol 20, 928-942.
Zhao, S., Grieshaber-Bouyer, R., Rao, D.A., Kolb, P., Chen, H., Andreeva, I., Tretter, T., Lorenz, H.M., Watzl, C., Wabnitz, G., et al. (2021). JAK inhibition prevents the induction of pro-inflammatory HLA-DR(+) CD90(+) RA synovial fibroblasts by IFN. Arthritis Rheumatol. 2021 Aug 25. doi: 10.1002/art.41958. Online ahead of print.
Zhu, S., Cao, L., Yu, Y., Yang, L., Yang, M., Liu, K., Huang, J., Kang, R., Livesey, K.M., and Tang, D. (2013). Inhibiting autophagy potentiates the anticancer activity of IFN1@/IFNalpha in chronic myeloid leukemia cells. Autophagy 9, 317-327.
論文の公開元へ
